journal article·2021-04-16Open access

Human Adipose Stem Cells (hASCs) Grown on Biodegradable Microcarriers in Serum- and Xeno-Free Medium Preserve Their Undifferentiated Status

Francesco Muoio, Stefano Panella, Valentin Jossen, Matias Lindner, Yves Harder, Michele Müller, Regine Eibl, Tiziano Tallone

Abstract

Human adipose stem cells (hASCs) are promising candidates for cell-based therapies, but they need to be efficiently expanded in vitro as they cannot be harvested in sufficient quantities. Recently, dynamic bioreactor systems operated with microcarriers achieved considerable high cell densities. Thus, they are a viable alternative to static planar cultivation systems to obtain high numbers of clinical-grade hASCs. Nevertheless, the production of considerable biomass in a short time must not be achieved to the detriment of the cells’ quality. To facilitate the scalable expansion of hASC, we have developed a new serum- and xeno-free medium (UrSuppe) and a biodegradable microcarrier (BR44). In this study, we investigated whether the culture of hASCs in defined serum-free conditions on microcarriers (3D) or on planar (2D) cell culture vessels may influence the expression of some marker genes linked with the immature degree or the differentiated status of the cells. Furthermore, we investigated whether the biomaterials, which form our biodegradable MCs, may affect cell behavior and differentiation. The results confirmed that the quality and the undifferentiated status of the hASCs are very well preserved when they grow on BR44 MCs in defined serum-free conditions. Indeed, the ASCs showed a gene expression profile more compatible with an undifferentiated status than the same cells grown under standard planar conditions.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Pluripotent Stem Cells Research · Mesenchymal stem cell research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Foundation for Cardiological Research and Education (FCRE), Cardiocentro Ticino Foundation, 6807 Taverne, Switzerland

Institute of Chemistry & Biotechnology, Competence Center of Biochemical Engineering & Cell Cultivation Technique Zurich University of Applied Sciences, 8820 Wädenswil, Switzerland

Sferalp SA, 6998 Monteggio, Switzerland

Department of Plastic, Reconstructive and Aesthetic Surgery, EOC, 6900 Lugano, Switzerland

Faculty of Biomedical Sciences, Università della Svizzera Italiana, 6900 Lugano, Switzerland

Funding

Swiss Federal Innovation Agency CTI (Commission for Technology and Innovation)

References (100+)

Show source-provided references
1. What we talk about when we talk about fat10.1016/j.cell.2013.12.012 ↗
2. Anatomical, Physiological, and Functional Diversity of Adipose Tissue10.1016/j.cmet.2017.12.002 ↗
3. Brown Adipose Crosstalk in Tissue Plasticity and Human Metabolism10.1210/endrev/bnz007 ↗
4. Sebo, Z.L., and Rodeheffer, M.S. (2019). Assembling the adipose organ: Adipocyte lineage segregation and adipogenesis in vivo. Development, 146.10.1242/dev.172098 ↗
5. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: A joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT)10.1016/j.jcyt.2013.02.006 ↗
6. Adipose tissue-derived stem cells in clinical applications10.1517/14712598.2013.823153 ↗
7. Discrete adipose-derived stem cell subpopulations may display differential functionality after in vitro expansion despite convergence to a common phenotype distribution10.1186/s13287-016-0435-8 ↗
8. Adipose stem cells: Biology and clinical applications for tissue repair and regeneration10.1016/j.trsl.2013.11.009 ↗
9. Recent advances in serum-free microcarrier expansion of mesenchymal stromal cells: Parameters to be optimized10.1016/j.bbrc.2015.09.078 ↗
10. Expansion of human mesenchymal stromal cells on microcarriers: Growth and metabolism10.1002/term.224 ↗
11. Serum-free culturing of mammalian cells—Adaption to and cryopreservation in fully defined media
12. A novel serum-free medium for the expansion of human mesenchymal stem cells10.1186/scrt8 ↗
13. Alternatives to the use of fetal bovine serum: Human platelet lysates as a serum substitute in cell culture media10.14573/altex.2011.4.305 ↗
14. Comparative Analysis of Media and Supplements on Initiation and Expansion of Adipose-Derived Stem Cells10.5966/sctm.2015-0148 ↗
15. Tsai, A.-C., Jeske, R., Chen, X., Yuan, X., and Li, Y. (2020). Influence of Microenvironment on Mesenchymal Stem Cell Therapeutic Potency: From Planar Culture to Microcarriers. Front. Bioeng. Biotechnol., 8.10.3389/fbioe.2020.00640 ↗
16. Expansion of human mesenchymal stem cells on microcarriers10.1007/s10529-011-0695-4 ↗
17. Dispersible and Dissolvable Porous Microcarrier Tablets Enable Efficient Large-Scale Human Mesenchymal Stem Cell Expansion10.1089/ten.tec.2020.0039 ↗
18. Serum-free media formulations are cell line–specific and require optimization for microcarrier culture10.1016/j.jcyt.2015.05.001 ↗
19. Panella, S., Muoio, F., Jossen, V., Harder, Y., Eibl-Schindler, R., and Tallone, T. (2021). Chemically Defined Xeno- and Serum-Free Cell Culture Medium to Grow Human Adipose Stem Cells. Cells, 10.10.3390/cells10020466 ↗
20. The effect of storage time on adipose-derived stem cell recovery from human lipoaspirates10.1159/000324892 ↗
21. Muoio, F., Panella, S., Lindner, M., Jossen, V., Harder, Y., Moccetti, T., Eibl, R., Müller, M., and Tallone, T. (2021). Development of a Biodegradable Microcarrier for the Cultivation of Human Adipose Stem Cells (hASCs) with a Defined Xeno- and Serum-Free Medium. Appl. Sci., 11.10.3390/app11030925 ↗
22. Rapid analysis of amino acids using pre-column derivatization10.1016/S0378-4347(00)85133-6 ↗
23. Jossen, V., Muoio, F., Panella, S., Harder, Y., Tallone, T., and Eibl, R. (2020). An Approach towards a GMP Compliant In-Vitro Expansion of Human Adipose Stem Cells for Autologous Therapies. Bioengineering, 7.10.3390/bioengineering7030077 ↗
24. High-Throughput Screening of Surface Marker Expression on Undifferentiated and Differentiated Human Adipose-Derived Stromal Cells10.1089/ten.tea.2015.0039 ↗
25. Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production10.1186/s13287-016-0370-8 ↗
26. Surface protein expression between human adipose tissue-derived stromal cells and mature adipocytes10.1007/s00418-005-0014-z ↗
27. CD36 promotes adipocyte differentiation and adipogenesis10.1016/j.bbagen.2012.04.001 ↗
28. CD36 Is a Marker of Human Adipocyte Progenitors with Pronounced Adipogenic and Triglyceride Accumulation Potential10.1002/stem.2635 ↗
29. Jossen, V., Eibl, R., Kraume, M., and Eibl, D. (2018). Growth Behavior of Human Adipose Tissue-Derived Stromal/Stem Cells at Small Scale: Numerical and Experimental Investigations. Bioengineering, 5.10.3390/bioengineering5040106 ↗
30. Quantifying In Vitro Growth and Metabolism Kinetics of Human Mesenchymal Stem Cells Using a Mathematical Model10.1089/ten.tea.2008.0328 ↗
31. Growth, Metabolism, and Growth Inhibitors of Mesenchymal Stem Cells10.1089/ten.tea.2008.0345 ↗
32. Effects of L-lactic acid and D,L-lactic acid on viability and osteogenic differentiation of mesenchymal stem cells10.1007/s11434-013-5798-y ↗
33. Influence of lactic acid on the proliferation, metabolism, and differentiation of rabbit mesenchymal stem cells10.1007/s10565-008-9113-7 ↗
34. Pref-1 marks very early mesenchymal precursors required for adipose tissue development and expansion10.1016/j.celrep.2014.06.060 ↗
35. Kang, S., Akerblad, P., Kiviranta, R., Gupta, R.K., Kajimura, S., Griffin, M.J., Min, J., Baron, R., and Rosen, E.D. (2012). Regulation of Early Adipose Commitment by Zfp521. PLoS Biol., 10.10.1371/journal.pbio.1001433 ↗
36. Pref-1 Regulates Mesenchymal Cell Commitment and Differentiation through Sox910.1016/j.cmet.2009.01.013 ↗
37. PPARγ and the global map of adipogenesis and beyond10.1016/j.tem.2014.04.001 ↗
38. Transcriptional control of preadipocyte determination by Zfp42310.1038/nature08816 ↗
39. The WNT Inhibitor Dickkopf 1 and Bone Morphogenetic Protein 4 Rescue Adipogenesis in Hypertrophic Obesity in Humans10.2337/db11-1419 ↗
40. The Wnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis10.1242/jcs.02975 ↗
41. Hormonal Regulation of Adipogenesis10.1002/cphy.c160047 ↗
42. Runx2, an inducer of osteoblast and chondrocyte differentiation10.1007/s00418-018-1640-6 ↗
43. Review of the adipose derived stem cell secretome10.1016/j.biochi.2013.06.001 ↗
44. Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk10.1016/j.cmet.2016.04.011 ↗
45. Cytokines: Names and Numbers You Should Care About10.2215/CJN.07590714 ↗
46. The Chemokine Superfamily Revisited10.1016/j.immuni.2012.05.008 ↗
47. Targeting Interleukin-6 Signaling in Clinic10.1016/j.immuni.2019.03.026 ↗
48. Cytokines and inflammation in adipogenesis: An updated review10.1007/s11684-018-0625-0 ↗
49. Burn Induces Browning of the Subcutaneous White Adipose Tissue in Mice and Humans10.1016/j.celrep.2015.10.028 ↗
50. Pentraxin 3 as a Prognostic Biomarker in Patients with Systemic Inflammation or Infection10.1155/2014/421429 ↗
51. Dual role of complement in adipose tissue10.1016/j.molimm.2008.09.013 ↗
52. Song, N.J., Kim, S., Jang, B.H., Chang, S.H., Yun, U.J., Park, K.M., Waki, H., Li, D.Y., Tontonoz, P., and Park, K.W. (2016). Small molecule-induced complement factor D (Adipsin) promotes lipid accumulation and adipocyte differentiation. PLoS ONE, 11.10.1371/journal.pone.0162228 ↗
53. VEGF in Signaling and Disease: Beyond Discovery and Development10.1016/j.cell.2019.01.021 ↗
54. Hepatocyte growth factor twenty years on: Much more than a growth factor10.1111/j.1440-1746.2010.06549.x ↗
55. Physiology of cultured animal cells10.1016/S0168-1656(97)00172-7 ↗
56. Schop, D. (2010). Growth and Metabolism of Mesenchymal Stem Cells Cultivated on Microcarriers. [Ph.D. Thesis, University of Twente].
57. Patterns of amino acid metabolism by proliferating human mesenchymal stem cells10.1089/ten.tea.2011.0223 ↗
58. Control of Stem Cell Fate by Physical Interactions with the Extracellular Matrix10.1016/j.stem.2009.06.016 ↗
59. Environmental physical cues determine the lineage specification of mesenchymal stem cells10.1016/j.bbagen.2015.02.011 ↗
60. Perspectives for clinical translation of adipose stromal/stem cells10.1155/2019/5858247 ↗
61. Alternatives to the use of fetal bovine serum: Serum-free cell culture
62. Fetal Bovine Serum (FBS): Past-Present-Future
63. Interstitial fluid concentrations of glycerol, glucose, and amino acids in human quadricep muscle and adipose tissue. Evidence for significant lipolysis in skeletal muscle10.1172/JCI118043 ↗
64. Composition of Interstitial Fluid10.1093/clinchem/41.10.1522 ↗
65. Manufacturing human mesenchymal stem cells at clinical scale: Process and regulatory challenges10.1007/s00253-018-8912-x ↗
66. Egger, D., Tripisciano, C., Weber, V., Dominici, M., and Kasper, C. (2018). Dynamic cultivation of mesenchymal stem cell aggregates. Bioengineering, 5.10.3390/bioengineering5020048 ↗
67. The therapeutic potential of three-dimensional multipotent mesenchymal stromal cell spheroids10.1186/s13287-017-0558-6 ↗
68. Microcarrier choice and bead-to-bead transfer for human mesenchymal stem cells in serum-containing and chemically defined media10.1016/j.procbio.2017.03.017 ↗
69. Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum-free microcarrier process10.1002/bit.25582 ↗
70. The subpopulation of CD105 negative mesenchymal stem cells show strong immunomodulation capacity compared to CD105 positive mesenchymal stem cells10.15419/bmrat.v6i4.538 ↗
71. CD146 (Cluster of Differentiation 146): An Adhesion Molecule Involved in Vessel Homeostasis10.1161/ATVBAHA.119.312653 ↗
72. CD146, a multi-functional molecule beyond adhesion10.1016/j.canlet.2012.11.049 ↗
73. Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNS10.1038/srep01687 ↗
74. Targeting endothelial CD146 attenuates colitis and prevents colitis-associated carcinogenesis10.1016/j.ajpath.2014.01.031 ↗
75. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis10.1093/brain/awp289 ↗
76. Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system10.1093/brain/aws212 ↗
77. Macrophagic CD146 promotes foam cell formation and retention during atherosclerosis10.1038/cr.2017.8 ↗
78. Novel flow cytometric approach for the detection of adipocyte subpopulations during adipogenesis10.1194/jlr.D065664 ↗
79. CD 36 initiates the secretory phenotype during the establishment of cellular senescence10.15252/embr.201745274 ↗
80. Glycosphingolipids of human embryonic stem cells10.1007/s10719-016-9706-y ↗
81. Embryonic Stem Cell Lines Derived from Human Blastocysts10.1126/science.282.5391.1145 ↗
82. Preimplantation Human Embryos and Embryonic Stem Cells Show Comparable Expression of Stage-Specific Embryonic Antigens10.1634/stemcells.20-4-329 ↗
83. Concise review: Evidence for CD34 as a common marker for diverse progenitors10.1002/stem.1661 ↗
84. Concerted regulation of CD34 and CD105 accompanies mesenchymal stromal cell derivation from human adventitial stromal cell10.1089/scd.2012.0263 ↗
85. Identification of Metabolically Distinct Adipocyte Progenitor Cells in Human Adipose Tissues10.1016/j.celrep.2019.04.010 ↗
86. Adipocyte extracellular matrix composition, dynamics and role in obesity10.1007/s00018-010-0263-4 ↗
87. Masson, O., Prébois, C., Derocq, D., Meulle, A., Dray, C., Daviaud, D., Quilliot, D., Valet, P., Muller, C., and Liaudet-Coopman, E. (2011). Cathepsin-D, a key protease in breast cancer, is up-regulated in obese mouse and human adipose tissue, and controls adipogenesis. PLoS ONE, 6.10.1371/journal.pone.0016452 ↗
88. Cathepsin L activity controls adipogenesis and glucose tolerance10.1038/ncb1623 ↗
89. Vidak, E., Javoršek, U., Vizovišek, M., and Turk, B. (2019). Cysteine Cathepsins and their Extracellular Roles: Shaping the Microenvironment. Cells, 8.10.3390/cells8030264 ↗
90. Cathepsin D-Many functions of one aspartic protease10.1016/j.critrevonc.2008.02.008 ↗
91. The insulin like growth factor and binding protein family: Novel therapeutic targets in obesity & diabetes10.1016/j.molmet.2018.10.008 ↗
92. Insulin-like growth factor I, growth hormone and insulin in white adipose tissue10.1016/j.beem.2005.07.011 ↗
93. Insulin-like growth factor 2 regulates the proliferation and differentiation of rat adipose-derived stromal cells via IGF-1R and IR10.1016/j.jcyt.2018.11.010 ↗
94. Differential effects of IGF-I, IGF-II and insulin in human preadipocytes and adipocytes—Role of insulin and IGF-I receptors10.1016/j.mce.2011.04.005 ↗
95. Control of Adipose Tissue Expandability in Response to High Fat Diet by the Insulin-like Growth Factor-binding Protein-410.1074/jbc.M113.545798 ↗
96. Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding10.1677/jme.1.01547 ↗
97. Proteomic screen identifies IGFBP7 as a novel component of endothelial cell-specific weibel-palade bodies10.1021/pr300010r ↗
98. Characterization of mac25/angiomodulin expression by high enothelial venule cells in lymphoid tissues and its identification as an inducible marker for activated endothelial cells10.1093/intimm/dxf102 ↗
99. A High Endothelial Venule Secretory Protein, Mac25/Angiomodulin, Interacts with Multiple High Endothelial Venule-Associated Molecules Including Chemokines10.4049/jimmunol.171.2.553 ↗
100. Angiomodulin Is a Specific Marker of Vasculature and Regulates Vascular Endothelial Growth Factor-A-Dependent Neoangiogenesis10.1161/CIRCRESAHA.109.196790 ↗